CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
April 23rd 2024
Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.
Imfinzi-Based Treatment Before, After Surgery May Significantly Improve Survival in Resectable NSCLC
March 11th 2023Patients with resectable non-small cell lung cancer treated with Imfinzi plus chemo before surgery or as monotherapy after surgery demonstrated significant improvements to event-free survival compared with those treated with neoadjuvant chemotherapy and surgery, study results show.